株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の能動植込み型医療機器市場:産業分析、市場規模、シェア、成長、動向、予測(2017年~2025年)

Active Implantable Medical Devices Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast, 2017 - 2025

発行 Transparency Market Research 商品コード 614735
出版日 ページ情報 英文 182 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.59円で換算しております。
Back to Top
世界の能動植込み型医療機器市場:産業分析、市場規模、シェア、成長、動向、予測(2017年~2025年) Active Implantable Medical Devices Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast, 2017 - 2025
出版日: 2018年02月19日 ページ情報: 英文 182 Pages
概要

当レポートでは、世界の能動植込み型医療機器市場について調査し、市場の概要、製品・処置・エンドユーザー・地域別の市場動向、市場規模の推移と予測、成長促進・阻害要因ならびに市場機会の分析、市場シェア、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

  • 市場の定義と範囲
  • 市場セグメンテーション
  • 主な調査目的
  • 調査のハイライト

第2章 前提条件と調査方法

第3章 エグゼクティブサマリー

第4章 世界の能動植込み型医療機器市場:概要

  • イントロダクション
  • 概要
  • 市場のダイナミクス
    • 成長要因
    • 阻害要因
    • 市場機会
  • 市場規模の推移と予測
  • ファイブフォース分析
  • 市場の見通し

第5章 能動植込み型医療機器市場の分析と予測:製品別

  • イントロダクション
  • 主な所見
  • 主要動向
  • 市場規模の予測:製品別
    • 心臓ペースメーカー
    • 植込み型除細動器(ICD)
    • 神経刺激装置
    • 人工内耳
    • 心室補助装置(VAD)
    • 植込み型心臓モニター
  • 市場魅力分析:製品別

第6章 能動植込み型医療機器市場の分析と予測:処置別

  • イントロダクション
  • 主な所見
  • 主要動向
  • 市場規模の予測:処置別
    • 心臓血管インプラント
    • 神経インプラント
    • 聴覚インプラント
    • その他
  • 市場魅力分析:処置別

第7章 能動植込み型医療機器市場の分析と予測:エンドユーザー別

  • イントロダクション
  • 主な所見
  • 主要動向
  • 市場規模の予測:エンドユーザー別
    • 病院
    • 外来外科センター
    • 専門診療所
  • 市場魅力分析:エンドユーザー別

第8章 能動植込み型医療機器市場の分析と予測:地域別

  • 主な所見
  • 市場規模の予測:地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力分析:地域別

第9章 北米

第10章 欧州

第11章 アジア太平洋

第12章 ラテンアメリカ

第13章 中東・アフリカ

第14章 競合情勢

  • 参入企業の競合分析(ティアおよび企業規模別)
  • 企業の市場シェア分析
  • 企業プロファイル(詳細 - 概要、財務、最新動向、戦略)
    • Abbott Laboratories
    • BIOTRONIK SE & Co. KG
    • Boston Scientific Corporation
    • Cochlear Ltd
    • Sonova Holding AG
    • LivaNova PLC
    • Medtronic Plc.
    • MED-EL Medical Electronics
    • Nurotron Biotechnology Co. Ltd
    • William Demant Holding A/S
図表

List of Tables

  • Table 01: Global Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by Product Type, 2017-2025
  • Table 02: Global Cardiac Pacemaker Market Size (US$ Mn) Forecast, by Product Type, 2017-2025
  • Table 03: Global Implantable Cardioverter Defibrillators (ICD) Market Size (US$ Mn) Forecast, by Product Type, 2017-2025
  • Table 04: Global Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by Procedure Type, 2017-2025
  • Table 05: Global Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by End user, 2017-2025
  • Table 06: Global Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by Region, 2017-2025
  • Table 07: North America Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by Product, 2017-2025
  • Table 08: North America Cardiac Pacemaker Market Size (US$ Mn) Forecast, by Product Type, 2017-2025
  • Table 09: North America Implantable Cardioverter Defibrillators (ICD) Market Size (US$ Mn) Forecast, by Product Type, 2017-2025
  • Table 10: North America Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by Procedure, 2017-2025
  • Table 11: North America Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by End user, 2017-2025
  • Table 12: North America Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by Country, 2017-2025
  • Table 13: Europe Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by Product, 2017-2025
  • Table 14: Europe Cardiac Pacemaker Market Size (US$ Mn) Forecast, by Product Type, 2017-2025
  • Table 15: Europe Implantable Cardioverter Defibrillators (ICD) Market Size (US$ Mn) Forecast, by Product Type, 2017-2025
  • Table 16: Europe Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by Procedure, 2017-2025
  • Table 17: Europe Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by End user, 2017-2025
  • Table 18: Europe Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by Country, 2017-2025
  • Table 19: Asia Pacific Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by Product, 2017-2025
  • Table 20: Asia Pacific Cardiac Pacemaker Market Size (US$ Mn) Forecast, by Product Type, 2017-2025
  • Table 21: Asia Pacific Implantable Cardioverter Defibrillators (ICD) Market Size (US$ Mn) Forecast, by Product Type, 2017-2025
  • Table 22: Asia Pacific Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by Procedure, 2017-2025
  • Table 23: Asia Pacific Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by End user, 2017-2025
  • Table 24: Asia Pacific Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by Country, 2017-2025
  • Table 25: Latin America Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by Product, 2017-2025
  • Table 26: Latin America Cardiac Pacemaker Market Size (US$ Mn) Forecast, by Product Type, 2017-2025
  • Table 27: Latin America Implantable Cardioverter Defibrillators (ICD) Market Size (US$ Mn) Forecast, by Product Type, 2017-2025
  • Table 28: Latin America Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by Procedure, 2017-2025
  • Table 29: Latin America Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by End user, 2017-2025
  • Table 30: Latin America Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by Country, 2017-2025
  • Table 31: Middle East and Africa Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by Product, 2017-2025
  • Table 32: Middle East and Africa Cardiac Pacemaker Market Size (US$ Mn) Forecast, by Product Type, 2017-2025
  • Table 33: Middle East and Africa Implantable Cardioverter Defibrillators (ICD) Market Size (US$ Mn) Forecast, by Product Type, 2017-2025
  • Table 34: Middle East and Africa Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by Procedure, 2017-2025
  • Table 35: Middle East and Africa Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by End user, 2017-2025
  • Table 36: Middle East and Africa Active Implantable Medical Devices Market Size (US$ Mn) Forecast, by Country, 2017-2025

List of Figures

  • Figure 01: Global Active Implantable Medical Devices Market Size (US$ Mn) Forecast, 2017-2025
  • Figure 02: Global Active Implantable Medical Devices Market Value Share Analysis, by Product Type, 2017 and 2025
  • Figure 03: Global Cardiac Pacemaker Market Revenue (US$ Mn), 2015-2025
  • Figure 04: Global Implantable Cardioverter Defibrillators Market Revenue, US$ Mn, 2015-2025
  • Figure 05: Global Nerve Stimulators Market Revenue (US$ Mn), 2015-2025
  • Figure 06: Global Insertable Cardiac Monitor Market Revenue, US$ Mn, 2015-2025
  • Figure 07: Global Cochlear Implants Market Revenue (US$ Mn), 2015-2025
  • Figure 08: Global Ventricular Assist Devices (VAD) Market Revenue, US$ Mn, 2015-2025
  • Figure 09: Active Implantable Medical Devices Market Attractiveness Analysis By Product Type
  • Figure 10: Global Active Implantable Medical Devices Market Value Share Analysis By Procedure Type, 2016 and 2024
  • Figure 07: Cardiovascular Implants Market Revenue, US$ Mn, 2015-2025
  • Figure 08: Neurological Implants Market Revenue, US$ Mn, 2015-2025
  • Figure 07: Hearing implants Market Revenue, US$ Mn, 2015-2025
  • Figure 08: Other Implants Market Revenue, US$ Mn, 2015-2025
  • Figure 10: Global Active Implantable Medical Devices Market Attractiveness Analysis, By Procedure Type
  • Figure 11: Global Active Implantable Medical Devices Market Value Share Analysis By End users, 2016 and 2024
  • Figure 12: Global Hospitals Market Revenue (US$ Mn), 2015-2025
  • Figure 13: Global Ambulatory Surgery Centers Market Revenue (US$ Mn), 2015-2025
  • Figure 14: Global Academic & Research Institutes Market Revenue (US$ Mn), 2015-2025
  • Figure 15: Active Implantable Medical Devices Market Attractiveness Analysis, by End user
  • Figure 16: Global Active Implantable Medical Devices Market Analysis By Region, 2017 and 2025
  • Figure 17: Global Active Implantable Medical Devices Market Attractiveness Analysis, By Region Type
  • Figure 18: North America Active Implantable Medical Devices Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 19: North America Market Attractiveness Analysis By Country
  • Figure 20: North America Active Implantable Medical Devices Market Value Share Analysis By Product Type, 2017 and 2025
  • Figure 21: North America Active Implantable Medical Devices Market Value Share Analysis By Procedure Type, 2017 and 2025
  • Figure 22: North America Active Implantable Medical Devices Market Value Share Analysis By End User Type, 2017 and 2025
  • Figure 23: North America Market Value Share Analysis By Country, 2017 and 2025
  • Figure 24: North America Market Attractiveness Analysis, by Product
  • Figure 25: North America Market Attractiveness Analysis, by Procedure
  • Figure 26: North America Market Attractiveness Analysis, by End User
  • Figure 27: Europe Active Implantable Medical Devices Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 28: Europe Market Attractiveness Analysis, by Country
  • Figure 29: Europe Market Value Share Analysis By Product Type, 2017 and 2025
  • Figure 30: Europe Market Value Share Analysis By Procedure Type, 2017 and 2025
  • Figure 31: Europe Active Implantable Medical Devices Market Value Share Analysis By End User Type, 2017 and 2025
  • Figure 32: Europe Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 33: Europe Market Attractiveness Analysis, by Product
  • Figure 34: Europe Market Attractiveness Analysis, by Procedure
  • Figure 35: Europe Market Attractiveness Analysis, by End User
  • Figure 36: Asia Pacific Active Implantable Medical Devices Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 37: Asia Pacific Market Attractiveness Analysis, by Country
  • Figure 38: Asia Pacific Market Value Share Analysis By Product Type, 2017 and 2025
  • Figure 39: Asia Pacific Market Value Share Analysis By Procedure Type, 2017 and 2025
  • Figure 40: Asia Pacific Active Implantable Medical Devices Market Value Share Analysis By End User Type, 2017 and 2025
  • Figure 41: Asia Pacific Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 42: Asia Pacific Market Attractiveness Analysis, by Product
  • Figure 43: Asia Pacific Market Attractiveness Analysis, by Procedure
  • Figure 44: Asia Pacific Market Attractiveness Analysis, by End User
  • Figure 45: Latin America Active Implantable Medical Devices Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 46: Latin America Market Attractiveness Analysis, by Country
  • Figure 47: Latin America Market Value Share Analysis By Product Type, 2017 and 2025
  • Figure 48: Latin America Market Value Share Analysis By Procedure Type, 2017 and 2025
  • Figure 49: Latin America Active Implantable Medical Devices Market Value Share Analysis By End User Type, 2017 and 2025
  • Figure 50: Latin America Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 51: Latin America Market Attractiveness Analysis, by Product
  • Figure 52: Latin America Market Attractiveness Analysis, by Procedure
  • Figure 53: Latin America Market Attractiveness Analysis, by End User
  • Figure 54: Middle East and Africa Active Implantable Medical Devices Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 55: Middle East and Africa Market Attractiveness Analysis, by Country
  • Figure 56: Middle East and Africa Market Value Share Analysis By Product Type, 2017 and 2025
  • Figure 57: Middle East and Africa Market Value Share Analysis By Procedure Type, 2017 and 2025
  • Figure 58: Middle East and Africa Active Implantable Medical Devices Market Value Share Analysis By End User Type, 2017 and 2025
  • Figure 59: Middle East and Africa Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 60: Middle East and Africa Market Attractiveness Analysis, by Product
  • Figure 61: Middle East and Africa Market Attractiveness Analysis, by Procedure
  • Figure 62: Middle East and Africa Market Attractiveness Analysis, by End User
  • Figure 63: Global Active Implantable Medical Devices Market Share Analysis By Cardiac Rhythm Management (2016)
  • Figure 64: Global Active Implantable Medical Devices Market Share Analysis By Neuromodulation (2016)
  • Figure 65: Global Active Implantable Medical Devices Market Share Analysis By Cochlear Implants (2016)
目次

Title:
Active Implantable Medical Devices Market (Product - Cardiac Pacemaker, Implantable Cardioverter Defibrillators (ICD), Nerve Stimulators, Insertable Cardiac Monitor (Implantable Monitoring Devices), Cochlear Implants, and Ventricular Assist Devices (VAD); Procedure - Cardiovascular Implants, Neurological Implants, and Hearing Implants; End User - Hospitals, Ambulatory Surgery Centers, and Specialty Clinics) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast, 2017 - 2025.

Global Active Implantable Medical Devices Market: Overview

Active Implantable Medical Devices are medical implantable devices like cochlear implants, implantable defibrillators, Implantable cardiac monitoring devices, implantable nerve stimulators, ventricular assist devices (VAD) and implantable cardiac pacemakers primarily used to detect, monitor, avert, alleviate or treat disease or conditions in the patients. This report analyzes the current and future prospects of the active implantable medical devices market based on product, procedure, end user and geography.

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of active implantable devices used in medical procedures in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases.

Global Active Implantable Medical Devices Market: Scope of the Study

The report provides estimated market size in terms of US$ Mn for product, procedure, end user, and geography for the period 2016 to 2025. The revenue generated from product type was calculated by considering the adoption rate of active medical implants across all geographies, number of product launched, average cost of products, trends in industry, and end user trends, among others. It comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market.

It also provides information and data analysis of the market with respect to market segments based on product, procedure, end user, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the active implantable medical devices market in the current and future scenario. The report also provides Porter's five force analysis that studies five factors and their impact on the active implantable medical devices market.

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The study also covers detailed country analysis contributing majorly in the active implantable medical devices market.

Companies Mentioned in the Report

The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the active implantable medical devices market include Boston Scientific Corporation, Medtronic Plc., Abbott Laboratories, Sonova Holding AG, BIOTRONIK SE & Co. KG, LivaNova PLC, Cochlear Ltd., Nurotron Biotechnology Co. Ltd., William Demant Holding A/S and MED-EL Medical Electronics. Collaboration agreements was the primary strategy adopted by the major market players to enter into the active implantable medical devices.

The global active implantable medical devices market has been segmented as follows:

By Product

  • Cardiac Pacemaker
    • Single Chamber Pacemaker
    • Dual Chamber Pacemaker
    • Others
  • Implantable Cardioverter Defibrillators (ICD)
    • Transvenous Implantable Cardioverter Defibrillators
    • Subcutaneous Implantable Cardioverter Defibrillators
    • Nerve Stimulators
    • Cochlear Implants
    • Ventricular Assist Devices (VAD)
  • Insertable Cardiac Monitor (Implantable Monitoring Devices)

By Procedure

  • Cardiovascular Implants
  • Neurological Implants
  • Hearing Implants
  • Others

By End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Clinics

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Israel
    • GCC countries
    • Rest of MEA

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Active Implantable Medical Devices Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Active Implantable Medical Devices Market Analysis and Forecasts, 2017-2025
  • 4.5. Porter's Five Force Analysis
  • 4.6. Market Outlook

5. Global Active Implantable Medical Devices Market Analysis and Forecasts, By Product

  • 5.1. Introduction & Definition
  • 5.2. Key Findings / Developments
  • 5.3. Key Trends
  • 5.4. Market Value Forecast By Product
    • 5.4.1. Cardiac Pacemaker
      • 5.4.1.1. Single Chamber Pacemaker
      • 5.4.1.2. Dual Chamber Pacemaker
      • 5.4.1.3. Others
    • 5.4.2. Implantable Cardioverter Defibrillators (ICD)
      • 5.4.2.1. Transvenous Implantable Cardioverter Defibrillators
      • 5.4.2.2. Subcutaneous Implantable Cardioverter Defibrillators
    • 5.4.3. Nerve Stimulators
    • 5.4.4. Cochlear Implants
    • 5.4.5. Ventricular Assist Devices (VAD)
    • 5.4.6. Insertable Cardiac Monitor (Implantable Monitoring Devices)
  • 5.5. Market Attractiveness By Product

6. Global Active Implantable Medical Devices Market Analysis and Forecasts, By Procedure

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Key Trends
  • 6.4. Market Value Forecast By Procedure
    • 6.4.1. Cardiovascular Implants
    • 6.4.2. Neurological Implants
    • 6.4.3. Hearing Implants
    • 6.4.4. Others
  • 6.5. Market Attractiveness By Procedure

7. Global Active Implantable Medical Devices Market Analysis and Forecasts, By End-User

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Key Trends
  • 7.4. Market Value Forecast By End-User
    • 7.4.1. Hospitals
    • 7.4.2. Ambulatory Surgery Centers
    • 7.4.3. Specialty Clinics
  • 7.5. Market Attractiveness By End-User

8. Global Active Implantable Medical Devices Market Analysis and Forecasts, By Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast By Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East and Africa
  • 8.3. Market Attractiveness By Country/Region

9.North America Active Implantable Medical Devices Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
    • 9.1.2. Key Trends
  • 9.2. Market Value Forecast By Product
    • 9.2.1. Cardiac Pacemaker
      • 9.2.1.1. Single Chamber Pacemaker
      • 9.2.1.2. Dual Chamber Pacemaker
      • 9.2.1.3. Others
    • 9.2.2. Implantable Cardioverter Defibrillators (ICD)
      • 9.2.2.1. Transvenous Implantable Cardioverter Defibrillators
      • 9.2.2.2. Subcutaneous Implantable Cardioverter Defibrillators
    • 9.2.3. Nerve Stimulators
    • 9.2.4. Cochlear Implants
    • 9.2.5. Ventricular Assist Devices (VAD)
    • 9.2.6. Insertable Cardiac Monitor (Implantable Monitoring Devices)
  • 9.3. Market Value Forecast By Procedure
    • 9.3.1. Cardiovascular Implants
    • 9.3.2. Neurological Implants
    • 9.3.3. Hearing Implants
    • 9.3.3. Others
  • 9.4. Market Value Forecast By End-User
    • 9.4.1. Hospitals
    • 9.4.2. Ambulatory Surgery Centers
    • 9.4.3. Specialty Clinics
  • 9.5. Market Value Forecast By Country
    • 9.5.1. U.S.
    • 9.5.2. Canada
  • 9.6. Market Attractiveness Analysis

10. Europe Active Implantable Medical Devices Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
    • 10.1.2. Key Trends
  • 10.2. Market Value Forecast By Product
    • 10.2.1. Cardiac Pacemaker
      • 10.2.1.1. Single Chamber Pacemaker
      • 10.2.1.2. Dual Chamber Pacemaker
      • 10.2.1.3. Others
    • 10.2.2. Implantable Cardioverter Defibrillators (ICD)
      • 10.2.2.1. Transvenous Implantable Cardioverter Defibrillators
      • 10.2.2.2. Subcutaneous Implantable Cardioverter Defibrillators
    • 10.2.3. Nerve Stimulators
    • 10.2.4. Cochlear Implants
    • 10.2.5. Ventricular Assist Devices (VAD)
    • 10.2.6. Insertable Cardiac Monitor (Implantable Monitoring Devices)
  • 10.3. Market Value Forecast By Procedure
    • 10.3.1 Cardiovascular Implants
    • 10.3.2.Neurological Implants
    • 10.3.3.Hearing Implants
    • 10.3.4.Others
  • 10.4. Market Value Forecast By End-User , 2015-2025
    • 10.4.1. Hospitals
    • 10.4.2. Ambulatory Surgery Centers
    • 10.4.3. Specialty Clinics
  • 10.5. Market Value Forecast By Country , 2015-2025
    • 10.5.1. Germany
    • 10.5.2. France
    • 10.5.3. U.K.
    • 10.5.4. Italy
    • 10.5.4. Spain
    • 10.5.4. Rest of Europe
  • 10.6. Market Attractiveness Analysis

11. Asia Pacific Active Implantable Medical Devices Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
    • 11.1.2. Key Trends
  • 11.2. Market Value Forecast By Product
    • 11.2.1. Cardiac Pacemaker
      • 11.2.1.1. Single Chamber Pacemaker
      • 11.2.1.2. Dual Chamber Pacemaker
      • 11.2.1.3. Others
    • 11.2.2. Implantable Cardioverter Defibrillators (ICD)
      • 11.2.2.1. Transvenous Implantable Cardioverter Defibrillators
      • 11.2.2.2. Subcutaneous Implantable Cardioverter Defibrillators
    • 11.2.3. Nerve Stimulators
    • 11.2.4. Cochlear Implants
    • 11.2.5. Ventricular Assist Devices (VAD)
    • 11.2.6. Insertable Cardiac Monitor (Implantable Monitoring Devices)
  • 11.3. Market Value Forecast By Procedure
    • 11.3.1 Cardiovascular Implants
    • 11.3.2.Neurological Implants
    • 11.3.3.Hearing Implants
    • 11.3.4.Others
  • 11.4. Market Value Forecast By End-User
    • 11.4.1. Hospitals
    • 11.4.2. Ambulatory Surgery Centers
    • 11.4.3. Specialty Clinics
  • 11.5. Market Value Forecast By Country
    • 11.5.1. Japan
    • 11.5.2. China
    • 11.5.3. India
    • 11.5.4. Australia
    • 11.5.5. Rest of Asia Pacific
  • 11.6. Market Attractiveness Analysis

12. Latin America Active Implantable Medical Devices Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
    • 12.1.2. Key Trends
  • 12.2. Market Value Forecast By Product
    • 12.2.1. Cardiac Pacemaker
      • 12.2.1.1. Single Chamber Pacemaker
      • 12.2.1.2. Dual Chamber Pacemaker
      • 12.2.1.3. Others
    • 12.2.2. Implantable Cardioverter Defibrillators (ICD)
      • 12.2.2.1. Transvenous Implantable Cardioverter Defibrillators
      • 12.2.2.2. Subcutaneous Implantable Cardioverter Defibrillators
    • 12.2.3. Nerve Stimulators
    • 12.2.4. Cochlear Implants
    • 12.2.5. Ventricular Assist Devices (VAD)
    • 12.2.6. Insertable Cardiac Monitor (Implantable Monitoring Devices)
  • 12.3. Market Value Forecast By Procedure
    • 12.3.1 Cardiovascular Implants
    • 12.3.2.Neurological Implants
    • 12.3.3.Hearing Implants
    • 12.3.4.Others
  • 12.4. Market Value Forecast By End-User
    • 12.4.1. Hospitals
    • 12.4.2. Ambulatory Surgery Centers
    • 12.4.3. Specialty Clinics
  • 12.5. Market Value Forecast By Country
    • 12.5.1. Brazil
    • 12.5.2. Mexico
    • 12.5.3. Rest of Latin America
  • 12.6. Market Attractiveness Analysis

13. Middle East and Africa Active Implantable Medical Devices Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
    • 13.1.2. Key Trends
  • 13.2. Market Value Forecast By Product
    • 13.2.1. Cardiac Pacemaker
      • 13.2.1.1. Single Chamber Pacemaker
      • 13.2.1.2. Dual Chamber Pacemaker
      • 13.2.1.3. Others
    • 13.2.2. Implantable Cardioverter Defibrillators (ICD)
      • 13.2.2.1. Transvenous Implantable Cardioverter Defibrillators
      • 13.2.2.2. Subcutaneous Implantable Cardioverter Defibrillators
    • 13.2.3. Nerve Stimulators
    • 13.2.4. Cochlear Implants
    • 13.2.5. Ventricular Assist Devices (VAD)
    • 13.2.6. Insertable Cardiac Monitor (Implantable Monitoring Devices)
  • 13.3. Market Value Forecast By Procedure
    • 13.3.1 Cardiovascular Implants
    • 13.3.2.Neurological Implants
    • 13.3.3.Hearing Implants
    • 13.3.4.Others
  • 13.4. Market Value Forecast By End-User
    • 13.4.1. Hospitals
    • 13.4.2. Ambulatory Surgery Centers
    • 13.4.3. Specialty Clinics
  • 13.5. Market Value Forecast By Country
    • 13.5.1. South Africa
    • 13.5.2. Israel
    • 13.5.3. GCC countries
    • 13.5.4. Rest of MEA
  • 13.6. Market Attractiveness Analysis

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 14.2. Market Share Analysis By Company (2016)
  • 14.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Business Overview
      • 14.3.1.3. Product Portfolio
      • 14.3.1.4. Financial Overview
      • 14.3.1.5. SWOT Analysis
      • 14.3.1.6. Strategic overview
    • 14.3.2. BIOTRONIK SE & Co. KG
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Business Overview
      • 14.3.2.3. Product Portfolio
      • 14.3.2.4. Financial Overview
      • 14.3.2.5. SWOT Analysis
      • 14.3.2.6. Strategic overview
    • 14.3.3. Boston Scientific Corporation
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Business Overview
      • 14.3.3.3. Product Portfolio
      • 14.3.3.4. Financial Overview
      • 14.3.3.5. SWOT Analysis
      • 14.3.3.6. Strategic overview
    • 14.3.4. Cochlear Ltd
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Business Overview
      • 14.3.4.3. Product Portfolio
      • 14.3.4.4. Financial Overview
      • 14.3.4.5. SWOT Analysis
      • 14.3.4.6. Strategic overview
    • 14.3.5. Sonova Holding AG
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Business Overview
      • 14.3.5.3. Product Portfolio
      • 14.3.5.4. Financial Overview
      • 14.3.5.5. SWOT Analysis
      • 14.3.5.6. Strategic overview
    • 14.3.6. LivaNova PLC
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Business Overview
      • 14.3.6.3. Product Portfolio
      • 14.3.6.4. Financial Overview
      • 14.3.6.5. SWOT Analysis
      • 14.3.6.6. Strategic overview
    • 14.3.7. Medtronic Plc.
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Business Overview
      • 14.3.7.3. Product Portfolio
      • 14.3.7.4. Financial Overview
      • 14.3.7.5. SWOT Analysis
      • 14.3.7.6. Strategic overview
    • 14.3.8. MED-EL Medical Electronics
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Business Overview
      • 14.3.8.3. Product Portfolio
      • 14.3.8.4. Financial Overview
      • 14.3.8.5. SWOT Analysis
      • 14.3.8.6. Strategic overview
    • 14.3.9. Nurotron Biotechnology Co. Ltd
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Business Overview
      • 14.3.9.3. Product Portfolio
      • 14.3.9.4. Financial Overview
      • 14.3.9.5. SWOT Analysis
      • 14.3.9.6. Strategic overview
    • 14.3.10. William Demant Holding A/S
      • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.10.2. Business Overview
      • 14.3.10.3. Product Portfolio
      • 14.3.10.4. Financial Overview
      • 14.3.10.5. SWOT Analysis
      • 14.3.10.6. Strategic overview
Back to Top